Truvestments Capital LLC Bristol Myers Squibb CO Transaction History

Truvestments Capital LLC

$363 Million
Q3 2024

A detailed history of Truvestments Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Truvestments Capital LLC holds 6,221 shares of BMY stock, worth $359,324. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,221

Previous 11,790 47.23%

Holding current value

$359,324

Previous $489,000 34.36%

% of portfolio

0.09%

Previous 0.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $220,866 - $288,195	-5,569 Reduced 47.23%	6,221 $321,000
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $105,213 - $138,515	-2,614 Reduced 18.15%	11,790 $489,000
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $1.12 Million - $1.27 Million	-23,332 Reduced 61.83%	14,404 $781,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $147,670 - $176,211	3,046 Added 8.78%	37,736 $1.94 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $64,026 - $71,591	1,106 Added 3.29%	34,690 $2.01 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $81,485 - $90,476	1,279 Added 3.96%	33,584 $2.15 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $239,447 - $271,587	3,644 Added 12.71%	32,305 $2.24 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $164,352 - $194,616	2,400 Added 9.14%	28,661 $2.06 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $66 - $39,342	-512 Reduced 1.91%	26,261 $1.87 Million
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $111,326 - $122,609	-1,533 Reduced 5.42%	26,773 $2.06 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $101,073 - $121,195	-1,644 Reduced 5.49%	28,306 $2.07 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $25,206 - $29,384	470 Added 1.59%	29,950 $1.87 Million
Q3 2021 Oct 29, 2021	BUY	$59.17 - $69.31 $112,482 - $131,758	1,901 Added 6.89%	29,480 $1.74 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $271,413 - $295,569	4,384 Added 18.9%	27,579 $1.84 Million
Q1 2021 May 18, 2021	BUY	$59.34 - $66.74 $350,877 - $394,633	5,913 Added 34.21%	23,195 $1.46 Million
Q4 2020 Feb 17, 2021	BUY	$57.74 - $65.43 $51,099 - $57,905	885 Added 5.4%	17,282 $1.07 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $719,081 - $796,836	12,521 Added 323.04%	16,397 $988,000
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $24,065 - $28,135	439 Added 12.77%	3,876 $227,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $232,324 - $337,622	-5,007 Reduced 59.3%	3,437 $191,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $231,040 - $301,372	4,695 Added 125.23%	8,444 $542,000
Q2 2019 Jul 15, 2019	BUY	$44.62 - $49.34 $60,370 - $66,757	1,353 Added 56.47%	3,749 $170,000
Q1 2019 Apr 12, 2019	SELL	$45.12 - $53.8 $190,812 - $227,520	-4,229 Reduced 63.83%	2,396 $114,000
Q3 2018 Oct 22, 2018	BUY	$55.19 - $62.25 $84,495 - $95,304	1,531 Added 30.05%	6,625 $411,000
Q2 2018 Aug 28, 2018	BUY	$50.53 - $62.98 $257,399 - $320,820	5,094 New	5,094 $282,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.

Account

Truvestments Capital LLC Bristol Myers Squibb CO Transaction History